Mutation of regulatory phosphorylation sites in PFKFB2 does not affect the anti-fibrotic effect of metformin in the kidney
Geoff Harley(Austin Health), David A. Power(The University of Melbourne)
Cited by 3
Related Papers
Mutation of regulatory phosphorylation sites in PFKFB2 worsens renal fibrosis
|Scientific Reports|2020|26
Activation of AMPK reduces the co-transporter activity of NKCC1
|Molecular Membrane Biology|2014|11